Esperion

Esperion Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with high cholesterol and other cardiovascular and cardiometabolic diseases. Their primary focus is on reducing LDL-cholesterol levels, a key factor in cardiovascular risk. Esperion has successfully brought two medications to market, NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe), which are approved in both the United States and Europe. These medications work through a unique mechanism of action, offering new options for patients who need to lower their cholesterol levels.

Esperion continues to invest in research and development, building a pipeline of potential future therapies. Their efforts include an ongoing cardiovascular outcomes trial (CVOT) and an investigational early-stage oral PCSK9 inhibitor program. They are also actively engaged in strategic partnerships with other companies to expand access to their existing products and to advance the development of new therapies. Esperion's mission is to deliver innovative medicines that help patients reach their treatment goals, contributing to healthier lives and a brighter future for cardiovascular health.

Esperion offers a fully remote working environment, flexible holidays, and generous paid time off, including paid volunteer time. This allows employees to maintain a healthy work-life balance and to pursue personal interests and community involvement.

Esperion offers competitive compensation and benefits to its employees. The company provides a fair and equitable base salary with performance-based bonuses, a 401k with company match, and restricted stock units. Esperion also provides comprehensive health plans, vision and dental insurance for employees and their families, including pets. Additionally, they offer a fully remote working environment, flexible holidays, and generous paid time off, including paid volunteer time.

Esperion Therapeutics is a biotech company dedicated to delivering innovative medicines that help patients reach their goals for managing cardiovascular and cardiometabolic diseases, particularly high cholesterol. Their mission focuses on improving patient outcomes by discovering, developing, and commercializing effective and affordable solutions that address unmet needs in these areas.

Esperion promotes a culture of collaboration, integrity, passion, and accountability, emphasizing a team-oriented approach that values diversity and fosters an inclusive environment. They prioritize their commitment to patients and believe in nurturing ideas, inspiring excellence, and generating excitement for those they work with.

Esperion fosters an inclusive environment that respects the different skills, experiences, and diverse backgrounds of its colleagues. The company strives to attract talent that optimizes its culture, empowers it to achieve its mission, and creates opportunities for growth. This commitment to diversity, equity, and inclusion is evident in its statement that the "patient is at the center of every decision" and its dedication to delivering innovative medicines that improve the lives of those they serve.